0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pharmaceutical Excipient Albumin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-21Q13483
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Excipient Albumin Market Research Report 2023
BUY CHAPTERS

Pharmaceutical Excipient Albumin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21Q13483
Report
September 2024
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Excipient Albumin - Market Size

The global market for Pharmaceutical Excipient Albumin was estimated to be worth US$ 715 million in 2023 and is forecast to a readjusted size of US$ 1245.7 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Pharmaceutical Excipient Albumin - Market

Pharmaceutical Excipient Albumin - Market

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipient Albumin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Excipient Albumin by region & country, by Type, and by Application.
The Pharmaceutical Excipient Albumin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipient Albumin.
Market Segmentation

Scope of Pharmaceutical Excipient Albumin - Market Report

Report Metric Details
Report Name Pharmaceutical Excipient Albumin - Market
Forecasted market size in 2030 US$ 1245.7 million
CAGR 8.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Human Serum Albumin
  • Recombinant Albumin
Segment by Application
  • Cell Culture Media
  • Medical Supplements
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pharmaceutical Excipient Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Pharmaceutical Excipient Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Pharmaceutical Excipient Albumin in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pharmaceutical Excipient Albumin - Market size in 2030?

Ans: The Pharmaceutical Excipient Albumin - Market size in 2030 will be US$ 1245.7 million.

Who are the main players in the Pharmaceutical Excipient Albumin - Market report?

Ans: The main players in the Pharmaceutical Excipient Albumin - Market are CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia

What are the Application segmentation covered in the Pharmaceutical Excipient Albumin - Market report?

Ans: The Applications covered in the Pharmaceutical Excipient Albumin - Market report are Cell Culture Media, Medical Supplements

What are the Type segmentation covered in the Pharmaceutical Excipient Albumin - Market report?

Ans: The Types covered in the Pharmaceutical Excipient Albumin - Market report are Human Serum Albumin, Recombinant Albumin

1 Market Overview
1.1 Pharmaceutical Excipient Albumin Product Introduction
1.2 Global Pharmaceutical Excipient Albumin Market Size Forecast
1.2.1 Global Pharmaceutical Excipient Albumin Sales Value (2019-2030)
1.2.2 Global Pharmaceutical Excipient Albumin Sales Volume (2019-2030)
1.2.3 Global Pharmaceutical Excipient Albumin Sales Price (2019-2030)
1.3 Pharmaceutical Excipient Albumin Market Trends & Drivers
1.3.1 Pharmaceutical Excipient Albumin Industry Trends
1.3.2 Pharmaceutical Excipient Albumin Market Drivers & Opportunity
1.3.3 Pharmaceutical Excipient Albumin Market Challenges
1.3.4 Pharmaceutical Excipient Albumin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Excipient Albumin Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Excipient Albumin Revenue by Company (2019-2024)
2.3 Global Pharmaceutical Excipient Albumin Players Sales Volume Ranking (2023)
2.4 Global Pharmaceutical Excipient Albumin Sales Volume by Company Players (2019-2024)
2.5 Global Pharmaceutical Excipient Albumin Average Price by Company (2019-2024)
2.6 Key Manufacturers Pharmaceutical Excipient Albumin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pharmaceutical Excipient Albumin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Excipient Albumin
2.9 Pharmaceutical Excipient Albumin Market Competitive Analysis
2.9.1 Pharmaceutical Excipient Albumin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Excipient Albumin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipient Albumin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Serum Albumin
3.1.2 Recombinant Albumin
3.2 Global Pharmaceutical Excipient Albumin Sales Value by Type
3.2.1 Global Pharmaceutical Excipient Albumin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Excipient Albumin Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Excipient Albumin Sales Value, by Type (%) (2019-2030)
3.3 Global Pharmaceutical Excipient Albumin Sales Volume by Type
3.3.1 Global Pharmaceutical Excipient Albumin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pharmaceutical Excipient Albumin Sales Volume, by Type (2019-2030)
3.3.3 Global Pharmaceutical Excipient Albumin Sales Volume, by Type (%) (2019-2030)
3.4 Global Pharmaceutical Excipient Albumin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cell Culture Media
4.1.2 Medical Supplements
4.2 Global Pharmaceutical Excipient Albumin Sales Value by Application
4.2.1 Global Pharmaceutical Excipient Albumin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Excipient Albumin Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Excipient Albumin Sales Value, by Application (%) (2019-2030)
4.3 Global Pharmaceutical Excipient Albumin Sales Volume by Application
4.3.1 Global Pharmaceutical Excipient Albumin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pharmaceutical Excipient Albumin Sales Volume, by Application (2019-2030)
4.3.3 Global Pharmaceutical Excipient Albumin Sales Volume, by Application (%) (2019-2030)
4.4 Global Pharmaceutical Excipient Albumin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Excipient Albumin Sales Value by Region
5.1.1 Global Pharmaceutical Excipient Albumin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Excipient Albumin Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Excipient Albumin Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Excipient Albumin Sales Value by Region (%), (2019-2030)
5.2 Global Pharmaceutical Excipient Albumin Sales Volume by Region
5.2.1 Global Pharmaceutical Excipient Albumin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pharmaceutical Excipient Albumin Sales Volume by Region (2019-2024)
5.2.3 Global Pharmaceutical Excipient Albumin Sales Volume by Region (2025-2030)
5.2.4 Global Pharmaceutical Excipient Albumin Sales Volume by Region (%), (2019-2030)
5.3 Global Pharmaceutical Excipient Albumin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pharmaceutical Excipient Albumin Sales Value, 2019-2030
5.4.2 North America Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pharmaceutical Excipient Albumin Sales Value, 2019-2030
5.5.2 Europe Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Excipient Albumin Sales Value, 2019-2030
5.6.2 Asia Pacific Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pharmaceutical Excipient Albumin Sales Value, 2019-2030
5.7.2 South America Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Value, 2019-2030
5.8.2 Middle East & Africa Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pharmaceutical Excipient Albumin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.5.2 China Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Excipient Albumin Sales Value, 2019-2030
6.9.2 India Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Excipient Albumin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CSL
7.1.1 CSL Company Information
7.1.2 CSL Introduction and Business Overview
7.1.3 CSL Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 CSL Pharmaceutical Excipient Albumin Product Offerings
7.1.5 CSL Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Introduction and Business Overview
7.2.3 Grifols Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Grifols Pharmaceutical Excipient Albumin Product Offerings
7.2.5 Grifols Recent Development
7.3 Takeda
7.3.1 Takeda Company Information
7.3.2 Takeda Introduction and Business Overview
7.3.3 Takeda Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Takeda Pharmaceutical Excipient Albumin Product Offerings
7.3.5 Takeda Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Pharmaceutical Excipient Albumin Product Offerings
7.4.5 Octapharma Recent Development
7.5 Hualan Bio
7.5.1 Hualan Bio Company Information
7.5.2 Hualan Bio Introduction and Business Overview
7.5.3 Hualan Bio Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hualan Bio Pharmaceutical Excipient Albumin Product Offerings
7.5.5 Hualan Bio Recent Development
7.6 CBPO
7.6.1 CBPO Company Information
7.6.2 CBPO Introduction and Business Overview
7.6.3 CBPO Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CBPO Pharmaceutical Excipient Albumin Product Offerings
7.6.5 CBPO Recent Development
7.7 Shanghai RAAS
7.7.1 Shanghai RAAS Company Information
7.7.2 Shanghai RAAS Introduction and Business Overview
7.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shanghai RAAS Pharmaceutical Excipient Albumin Product Offerings
7.7.5 Shanghai RAAS Recent Development
7.8 Kedrion
7.8.1 Kedrion Company Information
7.8.2 Kedrion Introduction and Business Overview
7.8.3 Kedrion Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Kedrion Pharmaceutical Excipient Albumin Product Offerings
7.8.5 Kedrion Recent Development
7.9 LFB Group
7.9.1 LFB Group Company Information
7.9.2 LFB Group Introduction and Business Overview
7.9.3 LFB Group Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LFB Group Pharmaceutical Excipient Albumin Product Offerings
7.9.5 LFB Group Recent Development
7.10 Albumedix
7.10.1 Albumedix Company Information
7.10.2 Albumedix Introduction and Business Overview
7.10.3 Albumedix Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Albumedix Pharmaceutical Excipient Albumin Product Offerings
7.10.5 Albumedix Recent Development
7.11 Biotest
7.11.1 Biotest Company Information
7.11.2 Biotest Introduction and Business Overview
7.11.3 Biotest Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Biotest Pharmaceutical Excipient Albumin Product Offerings
7.11.5 Biotest Recent Development
7.12 Merck
7.12.1 Merck Company Information
7.12.2 Merck Introduction and Business Overview
7.12.3 Merck Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Merck Pharmaceutical Excipient Albumin Product Offerings
7.12.5 Merck Recent Development
7.13 Ventria (InVitria)
7.13.1 Ventria (InVitria) Company Information
7.13.2 Ventria (InVitria) Introduction and Business Overview
7.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Product Offerings
7.13.5 Ventria (InVitria) Recent Development
7.14 HiMedia
7.14.1 HiMedia Company Information
7.14.2 HiMedia Introduction and Business Overview
7.14.3 HiMedia Pharmaceutical Excipient Albumin Sales, Revenue and Gross Margin (2019-2024)
7.14.4 HiMedia Pharmaceutical Excipient Albumin Product Offerings
7.14.5 HiMedia Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Excipient Albumin Industrial Chain
8.2 Pharmaceutical Excipient Albumin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Excipient Albumin Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Excipient Albumin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pharmaceutical Excipient Albumin Market Trends
    Table 2. Pharmaceutical Excipient Albumin Market Drivers & Opportunity
    Table 3. Pharmaceutical Excipient Albumin Market Challenges
    Table 4. Pharmaceutical Excipient Albumin Market Restraints
    Table 5. Global Pharmaceutical Excipient Albumin Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pharmaceutical Excipient Albumin Revenue Market Share by Company (2019-2024)
    Table 7. Global Pharmaceutical Excipient Albumin Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Pharmaceutical Excipient Albumin Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Pharmaceutical Excipient Albumin Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Pharmaceutical Excipient Albumin Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Pharmaceutical Excipient Albumin Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Pharmaceutical Excipient Albumin
    Table 13. Global Pharmaceutical Excipient Albumin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipient Albumin as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pharmaceutical Excipient Albumin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Pharmaceutical Excipient Albumin Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Pharmaceutical Excipient Albumin Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Pharmaceutical Excipient Albumin Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Pharmaceutical Excipient Albumin Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Pharmaceutical Excipient Albumin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Pharmaceutical Excipient Albumin Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Pharmaceutical Excipient Albumin Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Pharmaceutical Excipient Albumin Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Pharmaceutical Excipient Albumin Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Pharmaceutical Excipient Albumin Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Pharmaceutical Excipient Albumin Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Pharmaceutical Excipient Albumin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Pharmaceutical Excipient Albumin Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Pharmaceutical Excipient Albumin Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Pharmaceutical Excipient Albumin Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Pharmaceutical Excipient Albumin Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Pharmaceutical Excipient Albumin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Pharmaceutical Excipient Albumin Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Pharmaceutical Excipient Albumin Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Pharmaceutical Excipient Albumin Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Pharmaceutical Excipient Albumin Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Pharmaceutical Excipient Albumin Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Pharmaceutical Excipient Albumin Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Pharmaceutical Excipient Albumin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Pharmaceutical Excipient Albumin Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Pharmaceutical Excipient Albumin Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Pharmaceutical Excipient Albumin Sales Value by Region (2019-2024) & (%)
    Table 44. Global Pharmaceutical Excipient Albumin Sales Value by Region (2025-2030) & (%)
    Table 45. Global Pharmaceutical Excipient Albumin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Pharmaceutical Excipient Albumin Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Pharmaceutical Excipient Albumin Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Pharmaceutical Excipient Albumin Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Pharmaceutical Excipient Albumin Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Pharmaceutical Excipient Albumin Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Pharmaceutical Excipient Albumin Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Volume, (2025-2030) & (K Units)
    Table 57. CSL Company Information
    Table 58. CSL Introduction and Business Overview
    Table 59. CSL Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. CSL Pharmaceutical Excipient Albumin Product Offerings
    Table 61. CSL Recent Development
    Table 62. Grifols Company Information
    Table 63. Grifols Introduction and Business Overview
    Table 64. Grifols Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Grifols Pharmaceutical Excipient Albumin Product Offerings
    Table 66. Grifols Recent Development
    Table 67. Takeda Company Information
    Table 68. Takeda Introduction and Business Overview
    Table 69. Takeda Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Takeda Pharmaceutical Excipient Albumin Product Offerings
    Table 71. Takeda Recent Development
    Table 72. Octapharma Company Information
    Table 73. Octapharma Introduction and Business Overview
    Table 74. Octapharma Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Octapharma Pharmaceutical Excipient Albumin Product Offerings
    Table 76. Octapharma Recent Development
    Table 77. Hualan Bio Company Information
    Table 78. Hualan Bio Introduction and Business Overview
    Table 79. Hualan Bio Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Hualan Bio Pharmaceutical Excipient Albumin Product Offerings
    Table 81. Hualan Bio Recent Development
    Table 82. CBPO Company Information
    Table 83. CBPO Introduction and Business Overview
    Table 84. CBPO Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. CBPO Pharmaceutical Excipient Albumin Product Offerings
    Table 86. CBPO Recent Development
    Table 87. Shanghai RAAS Company Information
    Table 88. Shanghai RAAS Introduction and Business Overview
    Table 89. Shanghai RAAS Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Shanghai RAAS Pharmaceutical Excipient Albumin Product Offerings
    Table 91. Shanghai RAAS Recent Development
    Table 92. Kedrion Company Information
    Table 93. Kedrion Introduction and Business Overview
    Table 94. Kedrion Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Kedrion Pharmaceutical Excipient Albumin Product Offerings
    Table 96. Kedrion Recent Development
    Table 97. LFB Group Company Information
    Table 98. LFB Group Introduction and Business Overview
    Table 99. LFB Group Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. LFB Group Pharmaceutical Excipient Albumin Product Offerings
    Table 101. LFB Group Recent Development
    Table 102. Albumedix Company Information
    Table 103. Albumedix Introduction and Business Overview
    Table 104. Albumedix Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Albumedix Pharmaceutical Excipient Albumin Product Offerings
    Table 106. Albumedix Recent Development
    Table 107. Biotest Company Information
    Table 108. Biotest Introduction and Business Overview
    Table 109. Biotest Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Biotest Pharmaceutical Excipient Albumin Product Offerings
    Table 111. Biotest Recent Development
    Table 112. Merck Company Information
    Table 113. Merck Introduction and Business Overview
    Table 114. Merck Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Merck Pharmaceutical Excipient Albumin Product Offerings
    Table 116. Merck Recent Development
    Table 117. Ventria (InVitria) Company Information
    Table 118. Ventria (InVitria) Introduction and Business Overview
    Table 119. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Ventria (InVitria) Pharmaceutical Excipient Albumin Product Offerings
    Table 121. Ventria (InVitria) Recent Development
    Table 122. HiMedia Company Information
    Table 123. HiMedia Introduction and Business Overview
    Table 124. HiMedia Pharmaceutical Excipient Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. HiMedia Pharmaceutical Excipient Albumin Product Offerings
    Table 126. HiMedia Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Pharmaceutical Excipient Albumin Downstream Customers
    Table 130. Pharmaceutical Excipient Albumin Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pharmaceutical Excipient Albumin Product Picture
    Figure 2. Global Pharmaceutical Excipient Albumin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Pharmaceutical Excipient Albumin Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Pharmaceutical Excipient Albumin Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Pharmaceutical Excipient Albumin Report Years Considered
    Figure 7. Global Pharmaceutical Excipient Albumin Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Pharmaceutical Excipient Albumin Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Excipient Albumin Revenue in 2023
    Figure 10. Pharmaceutical Excipient Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Human Serum Albumin Picture
    Figure 12. Recombinant Albumin Picture
    Figure 13. Global Pharmaceutical Excipient Albumin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Pharmaceutical Excipient Albumin Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Pharmaceutical Excipient Albumin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Pharmaceutical Excipient Albumin Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Pharmaceutical Excipient Albumin Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Cell Culture Media
    Figure 19. Product Picture of Medical Supplements
    Figure 20. Global Pharmaceutical Excipient Albumin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Pharmaceutical Excipient Albumin Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Pharmaceutical Excipient Albumin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Pharmaceutical Excipient Albumin Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Pharmaceutical Excipient Albumin Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Pharmaceutical Excipient Albumin Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Pharmaceutical Excipient Albumin Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Pharmaceutical Excipient Albumin Sales Volume (%), (2019-2030)
    Figure 37. United States Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Pharmaceutical Excipient Albumin Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Pharmaceutical Excipient Albumin Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Pharmaceutical Excipient Albumin Sales Value by Application (%), 2023 VS 2030
    Figure 58. Pharmaceutical Excipient Albumin Industrial Chain
    Figure 59. Pharmaceutical Excipient Albumin Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Protein Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38B2538
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatoid Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5A13262
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Psoriasis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28R2574
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Rubber Stopper Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-15W7068
Sat Oct 12 00:00:00 UTC 2024

Add to Cart